Results 241 to 250 of about 838,579 (399)

Population-Based Estimates of Hepatitis E Virus-Associated Mortality in Bangladesh. [PDF]

J Infect Dis
Paul RC, Gidding HF, Nazneen A, Banik KC, Sumon SA, Paul KK, Akram A, Uzzaman MS, Tejada-Strop A, Kamili S, Luby SP, Hayen A, Gurley ES.   +12 more
europepmc   +1 more source

A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques.

, 1999
James C. Erker, Suresh M. Desai, G G Schlauder, George J. Dawson, I. K. Mushahwar   +4 more
openalex   +1 more source

Identification of 2 Novel Isolates of Hepatitis E Virus in Argentina [PDF]

, 2000
George G. Schlauder, Bernardo Frider, Silvia Sookoian, Gustavo C. Castaño, Isa K. Mushahwar   +4 more
openalex   +1 more source

Evaluation of Potential Effects of CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Fruquintinib in Healthy Subjects

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Cytochrome P450 (CYP) 3A plays a significant role in fruquintinib metabolism in vitro. This 2‐part, 2‐period fixed‐sequence study investigated the impact of CYP3A inhibition (itraconazole) and CYP3A induction (rifampin) on the pharmacokinetics (PK) of fruquintinib and M11, its main metabolite.
Martha Gonzalez, Zhao Yang, William R Schelman, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +5 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening

Hepatology Communications, EarlyView., 2022
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld   +17 more
wiley   +1 more source

Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney. [PDF]

Liver Int
Wahid A, Meyer N, Wundes C, Hüffner L, Janshoff S, Frericks N, Friesland M, Dinkelborg K, Aliabadi E, Laue F, Cornberg M, Maasoumy B, Bremer B, Pischke S, Müller T, Wiesch JZS, Benckert J, Ulrich RG, Hardtke S, Dörge P, Vondran F, Lohse A, Manns MP, Todt D, Wedemeyer H, Pietschmann T, Steinmann E, Gömer A, Behrendt P.   +28 more
europepmc   +1 more source

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter.

, 1998
S G√onther, Hans Will, Nils Piwon
openalex   +1 more source

Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1) [PDF]

, 2000
Israr-ul H. Ansari, Santosh Kumar Nanda, Hemlata Durgapal, Shipra Agrawal, Sujit K. Mohanty, Dinesh Gupta, Shahid Jameel, Subrat Kumar Panda   +7 more
openalex   +1 more source

Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open‐Label, Phase I Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana, Thuy Vu Craveiro, Thomas C. Marbury, Samuel Oberstein, George J. Atiee, Ben Tao, Takako Shimizu, Yvonne Lau, Malaz A. Abutarif   +8 more
wiley   +1 more source